"My life was sad before because I had to crawl on the ground," recalls Caesar Morales, a 24-year-old father in Mexico who, until recently, had only one limb and couldn't walk.
Western drug makers are increasingly outsourcing human clinical drug trials -- and India is getting the lion's share of the market. Is it putting millions at risk?
Researchers create the first nerve cells out of reprogrammed stem cells, using a technique that bypasses the destruction of embryos
Double-amputee sprinter Oscar Pistorius -- nicknamed the "blade runner" for his prosthetic limbs -- still hopes to make it to the Beijing Olympics despite failing to qualify for the individual 400-meter event, his coach said Thursday.
Medicine has much to learn from nature. There are literally millions of medical compounds out there that could cure diseases, help improve treatment and even protect us from some types of bacteria.
Wireless systems used by many hospitals to keep track of medical equipment can cause potentially deadly breakdowns in lifesaving devices such as breathing and dialysis machines
"This is a healthy 9-year-old boy. How in the world could his heart just stop?"
A double amputee sprinter has won the right to be eligible to compete at this summer's Olympic Games in Beijing after sport's highest court backed his appeal against a ban imposed by athletics authorities.
Insulin pumps are used by tens of thousands of teenagers worldwide with Type 1 diabetes, but they can be risky and have been linked to injuries and even deaths
The Food and Drug Administration looks like it's bowing to the inevitable this week and drawing the blueprint for the first-ever human experiments with human embryonic stem cells.
"My life was sad before because I had to crawl on the ground," recalls Caesar Morales, a 24-year-old father in Mexico who, until recently, had only one limb and couldn't walk.
Western drug makers are increasingly outsourcing human clinical drug trials -- and India is getting the lion's share of the market. Is it putting millions at risk?
Researchers create the first nerve cells out of reprogrammed stem cells, using a technique that bypasses the destruction of embryos
Double-amputee sprinter Oscar Pistorius -- nicknamed the "blade runner" for his prosthetic limbs -- still hopes to make it to the Beijing Olympics despite failing to qualify for the individual 400-meter event, his coach said Thursday.
Medicine has much to learn from nature. There are literally millions of medical compounds out there that could cure diseases, help improve treatment and even protect us from some types of bacteria.
Wireless systems used by many hospitals to keep track of medical equipment can cause potentially deadly breakdowns in lifesaving devices such as breathing and dialysis machines
"This is a healthy 9-year-old boy. How in the world could his heart just stop?"
A double amputee sprinter has won the right to be eligible to compete at this summer's Olympic Games in Beijing after sport's highest court backed his appeal against a ban imposed by athletics authorities.
Insulin pumps are used by tens of thousands of teenagers worldwide with Type 1 diabetes, but they can be risky and have been linked to injuries and even deaths
The Food and Drug Administration looks like it's bowing to the inevitable this week and drawing the blueprint for the first-ever human experiments with human embryonic stem cells.
It sounds like the stuff of Stephen King -- generating body parts, repairing damaged bone and growing back muscle like a gecko's severed tail. But stem cells represent a new wave of medicine that is more science than science fiction. One day they may not only lengthen an athlete's career but also provide the quick healing that Yankees pitcher Andy Pettitte was looking for when he used HGH to recover from elbow tendinitis in 2002.
I am one of the most avid sports fans you'll find," Se-Jin Lee says. It's true. He'll watch anything. Basketball. Football. Fútbol. Billiards on channel seven-hundred-whatever. As a graduate student in the '80s Lee used to sit in his car in the driveway with the radio on to listen to the games of faraway baseball teams. Even now, in his lab at Johns Hopkins Medical School in Baltimore, he easily rattles off the NCAA basketball tournament winners in order from 1964 to 2007. And, like anyone who values fair competition these days, he's disturbed by the issue of performance-enhancing drugs in sports.
Joshua Miller trotted off the football field after making a special-teams play and headed to the bench.
Whoever wins the White House, stem cell biotechs stand to reap the benefit from an incoming leader who is friendlier to stem cell researchers than President Bush, and that could lift stocks for the entire sector, experts say.
The first experiments using human embryonic stem cells in human subjects could begin within a few months, the chief executive of biotech Geron said Monday.
A Paralympic gold medal winner will not be allowed to compete in the Beijing Olympics later this year after athletics' governing body ruled that his specially-designed prosthetic limbs gave him an unfair advantage over other runners.
Marine Lance Cpl. Joshua Bleill lost both his legs above the knees when a bomb exploded under his Humvee while on patrol in Iraq on October 15, 2006. He has 32 pins in his hip and a 6-inch screw holding his pelvis together.
The world governing body for track and field has postponed its announcement on whether Paralympic star Oscar Pistorius, who runs on prosthetic limbs, can compete in this summer's Olympic Games, a spokesman said Thursday.
As women's basketball gets ready to honor one of its own who died this weekend at the Maggie Dixon Classic at Madison Square Garden, another heartfelt story is playing out across the country -- this one with a happy ending. After collapsing last May, first-year Washington State women's coach June Daugherty is bouncing back from her own bout with cardiac arrest
As women's basketball gets ready to honor one of its own who died this weekend at the Maggie Dixon Classic at Madison Square Garden, another heartfelt story is playing out across the country -- this one with a happy ending. After collapsing last May, first-year Washington State women's coach June Daughtery is bouncing back from her own bout with cardiac arrest
Ten years after a global pact to outlaw land mines, Afghanistan has seen genuine progress
The U.S. Supreme Court will hear arguments Tuesday in a case that could have major implications for Medtronic Inc. and other makers of medical devices.
The stem-cell breakthrough doesn't make up for six years of hypocrisy and lost research
The recent breakthroughs in stem cell research, where adult cells were "reprogrammed" to act like embryonic stem cells, are too early-stage to have much influence on Big Pharma's venture capital investments, experts say.
All sides involved in the controversy over the use of embryonic stem cells in research claimed vindication Tuesday after two teams of researchers reported having reprogrammed human skin cells to act like the stem cells, which have the potential of morphing into other cells and thereby curing disease.
In a pair of landmark studies, two groups of scientists announced Tuesday that they have reprogrammed human skin cells to act like embryonic stem cells, whose potential to mature into any other kind of cell in the body may ultimately prove key to curing a number of diseases.
Ever wanted to be a new you? Recent developments in cloning mean that day might be possible without therapy, a new diet or fitness regime.
The cause of implantable heart defibrillators took a hit Tuesday when researchers reported the results of two studies that failed to reach their objectives.
Companies that develop drugs using embryonic stem cell research could soon enter a bold new phase: human testing.
We're all guilty of using our cell phones in off-limits areas. But a new study shows that in hospitals they can be hazardous to medical equipment
What do you think the future holds for health? What developments are you hoping for? What challenges will we face? Send us your thoughts and we'll print the best ones here.
A nationwide push to put portable defibrillators in every school may not be worth the cost, a new study concludes
Prosthetic specialist Kevin Carroll travels the country tackling the toughest human amputation cases, so it was only natural that he was also drawn to Winter -- the only known dolphin to survive the loss of her powerful tail flukes.
Medtronic Inc. on Tuesday reported healthy gains in sales and earnings but analysts were disappointed by revenue growth.
The questionable stem cells created by a disgraced Korean researcher turn out to be a bona fide medical breakthrough
The first-ever spinal replacement disc for the neck could hit the U.S. market as soon as this month.
Early-stage studies in mice have shown that adult blood could be a richer source of insulin-creating stem cells than fertilized eggs, according to Dr. Yong Zhao, assistant professor at the University of Illinois.
Pushing back against the Democratic-led Congress, President Bush vetoed a bill Wednesday that would have eased restraints on federally funded embryonic stem cell research
Is George W. Bush right to veto the easing of federal funding restrictions on stem cell research?
The latest findings may expand the ways of generating customized stem cells -- and defuse the ethical objections
A California company now offers IVF patients the option of creating and storing their own stem cells
A procedure that replaces faulty genes in the blind might hold cures for all kinds of genetic diseases and for cancer
Some of the biotechs specializing in stem cell research took a hit Thursday after the Senate voted to remove a ban on federal funding for embryonic stem cell research but not by a wide enough margin to overcome an expected presidential veto.
The Senate turned its attention to plans to loosen President Bush's 2001 limits on embryonic stem-cell research Tuesday, but sponsors conceded their chances of overriding a threatened veto are uncertain.
Two new stem cell treatments could be entering the U.S. market next year.
The U.S. House of Representatives voted in favor of a bill that would lift President Bush's funding restrictions on research involving embryonic stem cells.
Stock prices for biotechs involved in stem cell technology continued to surge Monday, after soaring the prior week, after a new source of stem cells was announced, and as the House prepares to vote on whether to loosen federal funding for research involving embryonic stem cells.
Last year, Hwang Woo-suk was Korea's scientific Superman. He had three institutes, a stamp created in his honor, and, over the years, $60 million at his disposal. His face was plastered on buses in...
Stock prices for breast implant makers surged on Monday, following the FDA's decision on Friday to approve silicone implants, ending a 14-year ban for most women.
FDA approved silicone implants Friday, ending America's 14-year hiatus.
The 19th Century American lawyer turned author Christian Nestell Bovee once said, "It is the nature of thought to find its way into action."
It is a country where the call to prayer echoes throughout the capital every morning, where women must cover their heads at all times, where a Supreme Leader has the final say over everything.
The winners and losers from the mid-term elections weren't limited to the candidates on the ballots.
Voters in six states Tuesday approved ballot measures raising the minimum wage, joining 18 other states in setting a wage higher than the federal mark of $5.15 an hour, according to CNN projections.
The results of Missouri's referendum on stem cell research Tuesday could impact several biotechs specializing in that line of work.
After a nearly 20-year absence, Nixon-loving, Reagan-worshipping Alex P. Keaton is again slinging his political views on television.
On a warm August evening in Manhattan, the former leaders of medical-device maker Guidant joined their investment bankers in a private room at the tony Bouley restaurant to celebrate the sale of th...
Some key dates surrounding moral issues:
Moral issues sometimes drive voters to the polls not only to support or oppose a candidate, but also to make their voices heard on dozens of ballot measures dealing with issues like same-sex marriage, abortion or stem cell research.
Abiomed hit a major medical milestone when the FDA approved its artificial heart, but relatively few people are expected to use it and the company isn't likely to see significant sales from its new product at least a couple years.
Federal regulators have approved the first totally implanted artificial heart for patients who aren't eligible for a heart transplant, the Food and Drug Administration announced Tuesday.
For the first time since 1992 - the year Bill Clinton was elected, John Gotti was convicted and Los Angeles spiraled into riots - silicone breast implants may once again be available in America.
Since Deep Blue's victory over chess champion Gary Kasparov, humans have had to grow used to the idea of being eclipsed by computers in the most intellectual of mind games.
Embryonic stem cells might hold the secrets to curing paralysis and brain damage, but they've also garnered plenty of controversy with the anti-abortion lobby because they're harvested from embryos.
In July, George W. Bush quashed a bill to fund stem cell research, his first veto as President. The issue should loom large come November. Here's the impact on U.S. biotech.
To its advocates, including British Prime Minister Tony Blair and Californian Governor Arnold Schwarzenegger, stem cell therapies promise a medical revolution that will enable all of us to live longer, healthier lives.
Stem-cell research has joined global warming and evolution science as fields in which the very facts are put to a vote, a public spectacle in which data wrestle dogma.
Geron Corp.'s stock price rose significantly after the biotech announced that its experimental, stem-cell-based therapy for spinal cord injuries is safe in rats.
President Bush used his veto power Wednesday for the first time since taking office 5 1/2 years ago, saying that an embryonic stem-cell research bill "crossed a moral boundary."
George W. Bush seldom suffered personally from doing what's unpopular politically. In fact, you could argue that he has made a career of it, holding fast to positions that many voters reject, as a sign of strength in these dangerous times. So his willingness to exercise his first-ever veto this week on a bill that would expand federal funding for human embryonic-stem-cell research, which 2 out of 3 voters favor, is not just a way to stroke his political base. "People like leadership much better than a finger in the wind," says White House press secretary Tony Snow. As Bush explained to him while in St. Petersburg, Russia, for the G-8 summit last week, "I took a position. I believe in it. So that's what I'm going to do."
Senate Majority Leader Bill Frist introduced a bill Thursday to expand funding for embryonic stem cell research and said it would be debated and voted on in July.
Paralyzed rats are walking again, thanks to a new stem cell treatment; that's big news for the medical community ... and a 10-year wait for anybody wanting to make a buck off it.
Paralyzed rats partially regained the use of a previously immobile hind leg in a study in which scientists injected the rodents with stem cells from mouse embryos, according to researchers at Johns Hopkins University.
Celgene Corp., a biotech specializing in stem cell research, patented its methods for recovering stem cells from a human placenta after birth, the company said.
SAN FRANCISCO (Business 2.0 Magazine) - Investing in healthcare startups has long been a specialized business. It's one thing to kick the tires on an Internet startup; you just go to the website and start clicking away. It's another matter altogether to try to figure out if a biotech startup really has come up with a cure for cancer.
The panel for the first CNN Future Summit program is set. Originating from Singapore, the one hour program will focus on the long-term impact of research into the fields of robotics, cybernetics, genetics and stem cells.
For Fred Holper of Keyport, N.J., facing a diagnosis of terminal colon cancer at the age of 48 was tough, but his treatment decision wasn't. Immediately after surgery in 2001, he joined a clinical ...
Despite the controversies surrounding it, stem cell research is already changing lives. In the future, it offers hope for cures and treatments for a variety of diseases and disorders. We want to know what you think about the promise of stem cell research.
Chances are very good you've heard about stem cells. Whether from reports of their almost miraculous ability to cure and restore, or very public controversies over their source or the research itself, stem cells have been a hot topic in the news for years.
Ever since our ancestors first started making tools, humanity has been trying to go beyond its limitations to improve on the way our bodies interact with nature.
The Food and Drug Administration is recruiting outside help to monitor the safety of defibrillators for the first time, according to a news report.
Two best friends with the same first name, Jeff Brandt and Jeff Quelet, met years ago when both were in the early days of an unusual career: fitting patients with artificial limbs and body braces, ...
For six hours on Nov. 8, 2005, time moved so slowly for Frank Burroughs and Steve Walker that it seemed to stop altogether. The two had come to a dreary ballroom at a Holiday Inn in Gaithersburg, M...
Johnson & Johnson was going to buy Guidant to grow its strongest line of business. But J&J lost. So it needs to buy something else to keep its most promising business rolling.
Guidant Corp. formally ended its merger agreement with Johnson & Johnson and entered into a $27 billion accord with Boston Scientific, the medical device maker announced early Wednesday.
Tuesday is a big day for Johnson & Johnson: not only is it announcing fourth-quarter results, but it faces a crucial deadline in the ongoing bidding war over Guidant.
Is Guidant worth all this fuss?
British scientists are seeking permission to create hybrid embryos by fusing human cells with rabbit eggs.
Disgraced South Korean cloning scientist Hwang Woo-suk has apologized for publishing fake research on human stem cells, but said he was deceived by researchers at another lab.
South Korea's top university on Wednesday apologized for the scandal over Hwang Woo-suk's faked stem cell research, calling it a blemish on the country that embraced the scientist as a national hero.
One day after a panel investigating the work of disgraced South Korean scientist Hwang Woo-suk found that he faked claims of cloning human embryonic stem cells, the Seoul National University has issued a public apology.
A panel investigating the work of disgraced South Korean scientist Hwang Woo-suk has found that he faked claims of cloning human embryonic stem cells, in what could be the biggest cover-up in modern scientific history.
An expert panel from Seoul National University has dealt another blow to scientific claims by former researcher Hwang Woo-suk, saying he did not produce patient-specific stem cells as he had claimed in a landmark research paper.
Guidant just can't get any relief from regulators, but analysts and a potential corporate buyer refuse to give up on the beleaguered pacemaker company.
An expert panel from Seoul National University has said that South Korean researcher Hwang Woo-suk falsified results of nine of 11 stem cell lines he claimed to have created, casting more doubts on breakthrough claims he made in the U.S. journal Science in May.
Former "Baywatch" star Brooke Burns, who broke her neck last month after diving into her backyard pool, credits a friend, a paramedic firefighter, with saving her life.
It may not be your average Christmas present or gift for a newborn baby, but a British-based company says grandparents looking for a gift with a twist are increasingly investing in stem cells for their grandchildren.
A prominent South Korean scientist is defending himself against allegations of fraud in the already controversial field of stem-cell research.
Guidant Corporation has notified the Food and Drug Administration of several new reports about recent patient deaths associated with short circuits in its heart devices, according to a published report.
Hawaiian crooner Don Ho, who had an experimental procedure on his ailing heart earlier this week, says he's feeling much better and may return home to the islands within a few days.
| Most Viewed | Most Emailed | Top Searches |
| Most Viewed | Most Emailed | Top Searches |
Video
